Evidence map›Paper›PMID 36474520›Full record

ArticleRadiology case reports2023

Cerebellar infarction risk in a mild COVID-19 case.

Antigona Kabashi, Henri Fero, Artiona Gjini, Diana Dhimitri, Mimoza Spahiu, Fjolla Hyseni, Edlira Harizi, Kledisa Shemsi, Valon Vokshi, Arlind Decka and 11 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Radiology case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Antigona KabashiDepartment of Radiology, AAB College, Clinical of Radiology, University Clinical Center of Kosovo, Prishtina, Kosovo.
Henri FeroGP German Hospital International, Tirana, Albania.
Artiona GjiniGP German Hospital International, Tirana, Albania.
Diana DhimitriGP German Hospital International, Tirana, Albania.
Mimoza SpahiuGP German Hospital International, Tirana, Albania.
Fjolla HyseniDepartment of Pediatrics, NYU Langone Health, 403 East 34 street, New York, NY, USA.
Edlira HariziNeurology Department, Regional Hospital Durres, Tirana, Albania.
Kledisa ShemsiGeneral Practitioner Doctor, Tirana, Albania.
Valon VokshiDepartment of Anesthesiology and Reanimation, University Clinical Center of Kosovo, New York, USA.
Arlind DeckaDepartment of General Surgery, Westchester Medical Center, Valhalla, NY, USA.
Asm Al AminBangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.
Ahm AtaullahSher-E-Bangla, Medical College Hospital, Barisal, Bangladesh.
Livia CapiUniversity of Medicine of Tirana, Tirana, Albania.
Sepideh JahanianDepartment of General Surgery, Mayo Clinic, Rochester, MN, USA.
Fareeha NasirHarlem Hospital Center, New York, USA.
Ivan N AyalaKER Unit, Mayo Clinic, Rochester, MN, USA.
Juna MusaDepartment of General Surgery, Mayo Clinic, Rochester, MN, USA.
Jeton ShatriClinical of Radiology, University Clinical Center of Kosovo. Faculty of Medicine, Department of Anatomy, University of Prishtina, Prishtina, Kosovo.
Kreshnike DedushiClinical of Radiology, Faculty of Medicine University of Prishtina, University Clinical Center of Kosovo, Prishtina, Kosovo.
Florim LeniqiFaculty of Medicine, University of Gjakova, Gjakova, Kosovo.
Guri HyseniDepartment of Pediatric Surgery, University Clinical Center of Kosovo, Prishtina, Kosovo.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thrombotic events in SARS-COV-2 disease patients are frequent, especially in patients with comorbidities such as heart failure, hypertension, cancer, diabetes mellitus, kidney failure, vascular disease, and other pulmonary illnesses. In severe cases, in particular those of hospitalized patients with other comorbidities, the development of thrombotic events in spite of anticoagulation therapy has been observed. The main thrombotic events are pulmonary thromboembolism, cerebral ischemic stroke, and peripheral artery thrombosis. Despite the severity of SARS-COV-2 disease, some patients with the aforementioned comorbidities develop thrombotic events regardless of the severity of their SARS-COV-2 infection. In this setting, the cerebellum makes no exception as an uncommon, but still possible target for thrombotic events.

Indexed as

Cerebellar infarctionCOVID-19Pulmonary thromboembolismRole of MRISARS-COV-2SARS-COV-2 infection

Identifiers

PMID36474520
PMCPMC9714958

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.